Pain Therapeutics (PTIE) was among the biggest gainers on the Russell 2000 for September 2 as the stock popped 5.92% to $4.47, representing a gain of $0.25 per share. Some 160,347 shares traded hands on 1,225 trades, compared with an average daily volume of 198,674 shares out of a total float of 45,756,117. The stock opened at $4.23 and traded with an intraday range of $4.23 to $4.50.
After today's gains, Pain Therapeutics reached a market cap of $204,529,843. Pain Therapeutics has had a trading range between $6.22 and $2.48 over the last year, and it had a 50-day SMA of $4.72 and a 200-day SMA of $4.88.
The stock has a P/E Ratio of 7.70.
Pain Therapeutics, Inc., is a biopharmaceutical company that develops novel drugs. It has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma.
Pain Therapeutics is based out of Austin, TX and has some 8 employees. It's CEO is Remi Barbier.
For a full analysis of Pain Therapeutics, check out Equities.com's E.V.A. report.
The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
For more news on the financial markets, go to Equities.com. Also, learn more about our Small-Cap Stars. Register to become a member and leverage our proprietary research tools such as the Small-Cap Stars, and robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.